EBV-Positive DLBCL, NOS
specificA diffuse large B-cell lymphoma originally described in patients older than 50 years, but it has been increasingly recognized in younger patients. Epstein-Barr virus is present in all cases. There is no known history of immunodeficiency or prior lymphoma.
15
Centers
8
Active Trials
—
Cancer Funding
Top Centers for EBV-Positive DLBCL, NOS(15)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Fred Hutch Cancer CenterSeattle, WA NCI Comprehensive Active Research Program | 63.8 |
| 2 | NCI Comprehensive Active Research Program | 63.8 |
| 3 | Duke Cancer InstituteDurham, NC NCI Comprehensive Active Research Program | 63.8 |
| 4 | The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive Active Research Program | 63.8 |
| 5 | Roswell Park Comprehensive Cancer CenterBuffalo, NY NCI Comprehensive Active Research Program | 63.8 |
| 6 | The University of Arizona Cancer CenterTucson, AZ NCI Comprehensive Active Research Program | 63.8 |
| 7 | Medical College of Wisconsin Cancer CenterMilwaukee, WI Active Research Program | 63.8 |
| 8 | Boston University Cancer CenterBoston, MA Active Research Program | 63.8 |
| 9 | City of Hope Comprehensive Cancer CenterDuarte, CA NCI Comprehensive | 41.3 |
| 10 | University of Colorado Cancer CenterAurora, CO NCI Comprehensive | 41.3 |
| 11 | Huntsman Cancer Institute at the University of UtahSalt Lake City, UT NCI Comprehensive | 41.3 |
| 12 | Sidney Kimmel Comprehensive Cancer Center at JeffersonPhiladelphia, PA NCI Comprehensive | 41.3 |
| 13 | University of Cincinnati Cancer CenterCincinnati, OH | 41.3 |
| 14 | University of Texas Medical Branch Cancer CenterGalveston, TX | 41.3 |
| 15 | BC CancerVancouver, BC | 41.3 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →